ArticleJournal of oncology2022

Chemotherapy of Capecitabine plus Temozolomide for Refractory Pituitary Adenoma after Tumor Resection and Its Impact on Serum Prolactin, IGF-1, and Growth Hormone.

Xirui Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.